Ke Fu Medical: Controlling shareholder Xiezihao Investments increases its holdings of H shares, resulting in a shareholding ratio of 48.38%.

Kewell Medical announced that the controlling shareholder Xie's investment increased the company's H-shares by 1.3244 million shares through centralized bidding on July 17, 2026. The total shareholding proportion of Xie and the concerted action parties increased from 47.82% to 48.38%, with the change in shareholding reaching a multiple of 1%. After this equity change, the company's controlling shareholder and actual controller remain unchanged.